AI Genomics Target Triplebar as a rapidly growing biotech with a focus on AI-driven genomic modeling and high-throughput mutation screening. Sales opportunities exist in providing advanced computational infrastructure, data services, and AI model development support to accelerate their objective of an AI genomic model by early 2026.

Strategic Partnerships Leverage their past and ongoing collaborations (FrieslandCampina, Umami Bioworks) to position complementary platform or specialty protein production solutions, scale-up capabilities, and co-development services that align with their multi-product development pipeline.

Biologics Cost Highlight offerings that reduce biologics and food protein production costs, such as scalable expression systems, process optimization consulting, and CRO services, given their objective to lower production costs and accelerate time-to-market.

Funding Growth Align with their funded growth trajectory and leadership changes by offering flexible, milestone-based engagements, grant-readiness support, and partnerships that can scale with their fundraising cycles and expansion plans.

Cloud & Tech Stack Engage with their cloud-first strategy (Google Cloud, Azure) and continuous delivery practices by proposing integrated data pipelines, MLOps tooling, and cybersecurity/compliance services to support secure, scalable research and deployment of their AI genomic models.